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Variegated Expression of CD8 Resulting
from In Situ Deletion of Regulatory Sequences
element is a silencer that is located in the first intron of
the CD4 gene (Duncan et al., 1996; Sawada et al., 1994;
Siu et al., 1994), and it becomes active in CD8cells, thus
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eliminating the expression of CD4 in the CD8 subset.National Institute for Medical Research
Deleting the silencer element from the endogenous lo-The Ridgeway
cus results in expression of the CD4 gene in the CD8London NW7 1AA
population (Leung et al., 2001; Zou et al., 2001).United Kingdom
CD8 gene regulation has revealed an even more com-
plex system of control with impressively redundant in-
formation, as well as hierarchy, within the different ele-Summary
ments. Most thymocytes and T cells bearing an TCR
express CD8 as a disulphide-linked heterodimer com-The developmental and subset-specific expression of
posed of an  and a  chain (Jay et al., 1982; Ledbetterthe CD8 genes is under the control of a complex array
and Seaman, 1982; Ledbetter et al., 1981). In the mouseof regulatory elements distributed along the locus and
the two chains, CD8 (Lyt-2) and CD8 (Lyt-3), are en-characterized by DNaseI hypersensitivity. Here we de-
coded by two distantly related but closely linked genes.scribe the phenotype of mice in which hypersensitive
The murine CD8 gene locus consists of the CD8 andsites 1 and 2 (HSS1 and 2) of DNaseI hypersensitive
CD8 genes separated by 36 kb with the two genesCluster II (CII), which are located upstream of the CD8
organized in the same transcriptional orientation (Gor-gene, were deleted by targeted homologous recombi-
man et al., 1988).nation of the endogenous locus. Knockout mice ex-
Cloning and characterization of the CD8 gene locushibit a variegated expression of the CD8 gene, partic-
using transgenic mice identified an 80 kb genomic re-ularly among the immature CD48 TCRlo thymocyte
gion containing the CD8 and  genes with sufficientpopulation. We propose that HSS Cluster II regulatory
information for the proper developmental and subset-elements are essential in ensuring initiation of chro-
specific expression of these genes in transgenic micematin remodeling and establishment of an open con-
(Hostert et al., 1997a). DNaseI hypersensitivity analysisfiguration in all developing thymocytes that undergo
also led to the identification of four hypersensitive sitethe double-negative to double-positive transition. Fur-
(HSS) clusters (CI-CIV) with potential regulatory role. Sothermore, these sequences contribute to the levels of
far, using transgenic mice it has been shown that Clusterexpression of the CD8 gene.
II alone is unable to direct the expression of transgenes
to any subset of thymocytes or T cells (Hostert et al.,Introduction
1997b; Zhang et al., 1998). Cluster III, on the other hand,
is able to direct the expression of transgenic constructs
Thymocyte development proceeds through a complex
in the cells that have been positively selected toward
process, the stages of which can be identified by the
the CD8 lineage. A combination, however, of Cluster III
presence or absence of several surface molecules. with either Cluster II or Cluster IV elements restored the
Three major stages are defined by the expression pat- expression of transgenes in DP in addition to the CD8
tern of the two coreceptors CD4 and CD8. Thus, the SP subsets (Ellmeier et al., 1998; Hostert et al., 1998),
early thymocytes are characterized by the absence of indicating that Cluster II and IV both harbor elements
both CD4 and CD8 expression and are known as double- that can activate the locus in immature DP thymocytes.
negative (DN) thymocytes. Further maturation of thymo- Further evidence for redundancy of regulatory elements
cytes leads to the expression of both these markers, came from mice that had deleted some (Ellmeier et al.,
simultaneously rendering the cells double-positive (DP). 1998; Hostert et al., 1998) or all (Garefalaki, 2002) of
Positive selection, finally, leads to the appearance of Cluster III hypersensitive sites from the endogenous lo-
either CD4CD8 or CD4CD8 single-positive (SP) ma- cus by homologous recombination. In these mice, ex-
ture T cells. These cells, expressing only one of the pression of the CD8 locus is not affected in the CD8
coreceptors, migrate out of the thymus to populate pe- population found in the thymus or peripheral lymphoid
ripheral lymphoid organs (Fowlkes and Pardoll, 1989). organs, suggesting that the remaining elements within
The regulation of expression of the two coreceptors the locus were sufficient to ensure the expression of
has been the subject of numerous studies (reviewed in the CD8 and CD8 genes. In contrast, in these mice
Ellmeier et al., 1999). In the case of CD4 gene regulation, expression of the CD8 locus was severely affected in
two main regulatory elements are involved. One is a T cells that do not express the CD8 gene, such as the
T cell-specific enhancer located approximately 13 kb intraepithelial (IEL) TCR or TCR T cells. These data
upstream of the transcriptional start site (Sawada and imply that in the absence of activation of the Cluster IV
Littman, 1993), which can direct the expression of CD4 (CD8 gene and environs), Cluster III sequences be-
in both CD4CD8 and CD4CD8 T cells; the second come indispensable in ensuring expression from the
CD8 gene.
In order to unravel further the role that Cluster II plays1Correspondence: dkioussis@nimr.mrc.ac.uk
in the context of the rest of the regulatory elements,2 Present address: ICR, Chester Beatty Laboratories, London SW3
6JB, United Kingdom. we generated mice in which the two upstream DNaseI
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Figure 1. Deletion of DNaseI-HSS CII-1 and CII-2 by Homologous Recombination
(A) Map of the CD8 gene locus showing the location of the CD8 and CD8 genes (filled boxes, translated exons; open boxes, untranslated
exons). Restriction enzyme sites are indicated by vertical bars (B, BamHI), and the locations of DNaseI-HSS clusters are shown by vertical
arrows and labeled CI to CIV.
hypersensitive sites of Cluster II (CII-1 and CII-2) have these CD48 and CD48lo cells bear characteristics
of immature thymocytes. As a result of the incompletebeen deleted from the endogenous CD8 gene locus.
Expression of CD8 is affected in the thymus of these activation of the CD8 locus, these mice have reduced
numbers of mature CD8 SP cells in the thymus andmice so that a large percentage of the cells have a
CD48 or CD48lo phenotype. Only a proportion of cells peripheral lymphoid organs and exhibit lower levels of
CD8 expression on their surface.activate the locus fully to generate classical double-
positive CD48 immature thymocytes. The majority of We propose that Cluster II is essential for the timely
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and full remodeling of the chromatin in the CD8 gene mutant fragment, as detected with the 0.6 kb B/E probe
shown in Figure 1B. After deletion of the neomycin gene,locus and that its absence induces variegation of ex-
pression. the 6.9 kb mutant fragment is converted to an even
smaller 5.5 kb fragment, as detected with the same
probe. Out of 22 heterozygous mice born from the chi-Results
meras, 20 were found to have deleted the neomycin
gene while two mice still contained the neomycin geneGeneration of Homozygous CII Mutant Mice
In order to remove DNaseI-HSS CII-1 and CII-2 of Cluster in their genome. Mutant heterozygous mice were bred to
homozygocity for the mutated locus. Such mice heterozy-II from the mouse genome, a targeting construct was
generated as described in the Experimental Procedures gous and homozygous for the deletion are CII/1,2neo
and CII1,2/1,2neo and for simplicity’s sake in this papersection and as shown in Figure 1B. As nonmammalian
genes, such as the neomycin resistance gene, have are designated as CII/wt and CII, respectively. Figure
1C shows the Southern blot analysis of wild-type 129/been shown to affect the expression of gene loci in
which they have integrated (Garefalaki, 2002; Mei et al., Sv, CII/wt (with or without neo), and CII homozygous
mutant mice and confirms the predicted conversion of2000; Ramirez et al., 2001), we sought to remove it from
the genome of the mutant mice. For this purpose, the the 8.9 kb wild-type BamHI fragment to a smaller 6.9
kb mutant fragment before deletion of the neomycintargeting construct was linearized and used to transfect
PC3 embryonic stem cells (O’Gorman et al., 1997). This gene and to a 5.5 kb mutant fragment after deletion of
the neomycin gene, as detected with the 0.6 kb B/E129/Sv ES cell line was generated from mice transgenic
for the CRE recombinase gene under the control of prot- probe shown in Figure 1B. All the mice described in this
paper have had the neo gene removed.amine-1 promoter that is active in the terminal, haploid
stages of spermatogenesis. The CRE recombinase is
not expressed in the ES cells, but it is transiently ex- Expression of CD8 Is Affected in Thymocytes
and Peripheral T Cell Subsets by Deletionpressed in the male germ line and therefore leads to
the deletion of loxP-flanked genes in the germ line of the of HSS-1 and 2 of Cluster II
In order to examine the effect of CII deletion on CD8male mice. Thus, using the PC3 ES cell line offers the
advantage that the phloxed neomycin resistance gene expression, lymph node cells and thymocytes were iso-
lated from wild-type 129/Sv and CII homozygous mu-in the targeted locus is deleted from the mouse genome
in the first generation of offspring. tant mice (derived from two independent ES clones) and
stained with anti-CD4 and anti-CD8. The result wasThe targeting event replaces a 3.4 kb genomic region
containing the Cluster II DNaseI-HSS CII-1 and CII-2 representative of both clones. Absolute numbers of total
thymocytes or CD4 cells in peripheral organs appearedwith the neomycin resistance gene but leaves intact the
third hypersensitive site of Cluster II that is the promoter unaffected (data not shown). Figure 2 shows the analysis
of lymph node cells (top panel) or thymocytes (bottomof the CD8 gene. Southern blot analysis of 264 neore-
sistant clones showed that 17 had undergone homolo- panel) isolated from 129/Sv wild-type control mice (left-
hand side) and CII homozygous mutant mice (right-gous recombination. Five of the positive clones were
expanded, and the integrity of the locus was verified hand side) stained with the above combination of anti-
bodies. Cells were analyzed by plotting CD8 againstwith additional probes located upstream or within the
targeted region (data not shown). Two of these clones CD4 and electronically gating the different cell popula-
tions. The percentages of cells falling in each gate arewere checked for a euploid karyotype and were injected
into 3.5 day C57BL/6 blastocysts to generate chimeric shown in the quadrants of the dot plots. This analysis
shows that in peripheral T lymphocytes there is a sub-mice. Chimeric males were bred to C57Bl/10 wild-type
females, and germline transmission was determined by stantial reduction in the percentage of cells that express
CD8 in CII mice compared to the wild-type control.agouti coat color of the offspring. In male chimeric mice,
expression of CRE recombinase in the germline resulted This results in an increase of the CD4:CD8 ratio from
2–3:1 in the wild-type control animals to 6:1 in CIIin the deletion of the loxP-flanked neomycin resistance
gene from the genome of the majority of the offspring mutant mice, while the absolute number of CD4 cells
remains unaltered. In addition, the CD8 mean fluores-(Figure 1C).
Because of the replacement of a 3.4 kb genomic re- cence intensity (MFI) in CII mice was decreased com-
pared to the 129/Sv control mice by 25% (from 510gion with the 1.4 kb neomycin gene, the 8.9 kb wild-
type BamHI fragment is converted to a smaller 6.9 kb [n  6] to 383 [n  7]).
(B) Diagram of the murine CD8 gene locus showing (a) the 1,2CII targeting construct, (b) DNaseI-HSS Cluster CII, (c) the targeted allele, and
(d) the targeted allele after deletion of the neomycin resistance gene. The neomycin resistance gene (open box, labeled neo) was flanked by
4.7 kb 5	 and 3.2 kb 3	 homologous DNA sequences (filled boxes). Restriction enzyme sites are shown by vertical bars and are labeled as
follows: B, BamHI; E, EcoRI. Vertical arrows indicate Cluster II DNaseI-HSS, and the probe (0.6 kb B/E genomic fragment) used to detect
homologous recombination events and deletion of the neomycin gene is shown as a gray horizontal bar. Horizontal arrows illustrate the
expected BamHI fragments hybridizing with the probe (8.9 kb wild-type allele, 6.9 kb targeted allele, and 5.5 kb targeted allele after deletion
of neomycin gene).
(C) Southern blot analysis of 129/Sv wild-type, CII homozygous, CII/wt neo heterozygous, and CII/wt heterozygous mutant mice. The
replacement of 3.4 kb genomic region with the neomycin resistance gene results in the reduction of a wild-type 8.9 kb BamHI fragment to a
mutant 6.9 kb BamHI fragment. After deletion of the neomycin gene, the 6.9 kb mutant fragment is converted to a smaller 5.5 kb fragment.
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Figure 2. Expression of CD8 Is Affected in Thymocytes and Peripheral T Cell Subsets by the Deletion of DNaseI-HSS CII-1 and CII-2
Analysis of 129/Sv wild-type and CII homozygous mutant mice by flow cytometry. Lymph node cells and thymocytes were isolated and
stained with antibodies against CD8 and CD4. T cell and thymocyte subsets were resolved by plotting CD4 against CD8. Percentages of
CD4 SP, CD8 SP, CD4CD8 DP, and CD4CD8 DN cell subsets are indicated in the quadrants, and mean fluorescence intensities (MFI)
for CD8 are also shown. Seven mice were analyzed with similar results.
Similarly, in thymocytes of CII mutant mice, the level CD4 cells caused by the deletion of Cluster II sequences.
Alternatively, they may represent thymocytes in the pro-of CD8 expression is lower both in DP and in CD8
SP cells compared to the wild-type controls, and the cess of differentiation that failed to express the CD8
gene. In order to distinguish between the two possibili-numbers of CD8 SP cells are decreased in CII thy-
muses. More strikingly, however, in the CII mutant ties, we have examined the pattern of expression on
these cells of several markers that are modulated inmice, only 48.5% of the thymocytes appear to be DP,
compared to 87.2% in the wild-type control. In contrast, different stages of development. TCR, CD69, and CD5
are surface molecules that are upregulated during thethere is an increase in the number of cells that fall into
the CD4 SP compartment in CII mutant mice (46.8%) late stages of maturation following positive selection.
In contrast, HSA is a molecule that is downregulatedcompared to the wild-type control (5.6%). In addition,
staining of lymphocytes with an anti-CD8 antibody during this process. Thymocytes isolated from 129/Sv
wild-type mice (left hand side, Figure 3A) and CII mu-(data not shown) showed that on CD8 SP cells the CD8
molecule is in the form of CD8 heterodimers, indicat- tant mice (right hand side, Figure 3A) were stained with
antibodies against CD4, CD8, and either TCR, CD5,ing that the CD8 gene is active in these cells.
We conclude that deletion of Cluster II affects the CD69, or HSA. Cells were analyzed by gating the CD48
population and determining the expression of the matu-levels of expression of the CD8 gene and causes an
abnormal subset distribution in the thymus which shows ration markers.
As shown in Figure 3A, in wild-type mice the majorityfewer DP and CD8 SP cells and an increase in cells with
a CD4 SP phenotype. of the cells falling within the CD4 gate exhibit the ex-
pected mature pattern of expression of TCR, CD69,
CD5, and HSA. In contrast, large numbers of CD4 cellsThymocytes Appearing within the CD4 SP Gate
found in the thymuses of CII mice show levels of ex-Have an Immature Phenotype
pression consistent with an immature phenotype ofAs described in the previous section, thymuses of CII
these cells. It should be noted, however, that within thismice contain a large number of cells falling within the
CD4 SP population, the proportion and the number ofCD4 SP gate. These cells could arise because of a
diversion of the lineage commitment process toward cells that exhibit mature characteristics (TCRhi,
Knockout of CD8 Gene CII Regulatory Region
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Figure 3. Thymocytes Appearing within the CD4 SP Gate Have an Immature Phenotype
(A) Thymocyte analysis of 129/Sv wild-type and CII homozygous mutant mice stained with anti-CD8, anti-CD4, and with either anti-TCR,
anti-CD69, anti-CD5, or anti-HSA. Cell populations were identified by plotting CD4 against CD8. Percentages of CD4 SP, CD8 SP, CD4CD8
DP, and CD4CD8 DN cell subsets are indicated in the quadrants. CD4CD8 populations were gated as indicated in the dot plots and
analyzed for cell surface maturation marker expression in the histograms shown underneath the corresponding dot plot. The percentages of
cells positive for each maturation marker are shown in the histograms. Nine homozygous mice were analyzed for TCR expression, and two
were analyzed for the other maturation markers.
(B) Thymocyte analysis of C57B1/10 wild-type and CII homozygous mutant mice stained with anti-CD8, anti-CD4, and 7AAD. Cell populations
were identified by plotting CD4 against CD8. Different cell populations were gated as indicated in the dot plots (gates A, B, C, D, and E) and
analyzed for 7AAD labeling in the histograms shown underneath the corresponding dot plot. The percentages of cells labeled with 7AAD are
shown in the histograms. (A: DN, double-negative; B: DP, double-positive; C: CD4 INT, CD4 intermediate; D: CD4; E: CD8).
CD69hi, CD5hi, HSAlo) are similar between wild-type and could be a direct cis effect on the locus due to the
removal of the CII sequences. Alternatively, this couldCII mice. These conclusions were further supported
be the result of an effect in trans that results in a develop-by staining the same thymuses with 7AAD. 7AAD stain-
mental disturbance at the DN to DP transition. Accordinging can distinguish the number of cells that are in cycle.
to this hypothesis, thymocytes in the mutant mice areFigure 3B shows that in normal thymuses the DN and
allowed to express the CD4 gene but fail to activate theDP immature cells contain a significant proportion of
CD8 locus due to the absence of transcription factorscycling cells, whereas almost none can be detected in
normally present in the subsequent (DP) developmentalthe CD4 SP population. In contrast, in the thymuses of
stage. In order to distinguish between these two possi-CII mice the CD4 population contains an increased
bilities, we took advantage of the existence of two allelicproportion of cells in cycle.
forms of the CD8 gene (Lyt-2.1 and Lyt-2.2, referredWe conclude that deletion of CII sequences from the
to in this paper as CD8.1 and CD8.2, respectively) forCD8 locus does not affect the fate of decisions toward
which specific monoclonal antibodies are available.CD4 SP matures T cells. Rather, the increased numbers
Thus, heterozygous mutant mice (CII-CD8.2/wt-CD8.1)of thymocytes falling within the CD4 SP gate are imma-
were analyzed using appropriate allele-specific antibod-ture cells that would normally appear in the DP positive
ies. Homozygous CII-CD8.2 mice were crossed togate but fail to do so due to lack of CD8 expression on
CBA/Ca mice (homozygous for the wild-type CD8.1 al-their surface.
lele), and F1 progeny were analyzed for the expression
of CD8 molecules arising from the wild-type (CD8.1) or
In CII Thymuses the Two Allelic CD8 Loci Are the mutant CII (CD8.2) allele. If the effect of the CII
Regulated Independently deletion is in trans, then in the CII/wt heterozygous
In CII mice the increase of immature, phenotypically mice the presence of the fully functional CD8.1 allele
would allow the cells to complete the transition fromCD4SP cells and their inability to express the CD8 gene
Immunity
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Figure 4. In CII Thymuses the Two Allelic
CD8 Loci Are Regulated Independently
FACS analysis of (129/Sv x CBA/Ca) F1 wild-
type and CII/wt heterozygous mutant mice.
The wild-type mice express a wt-CD8.1 allele
and a wt-CD8.2 allele, whereas the mutant
mice express a wt-CD8.1 and a CII-CD8.2
allele. Thymocytes were isolated and stained
with anti-CD8.1, anti-CD4, and anti-CD8.2.
Cell populations were identified by plotting
CD4 against CD8.1 (top dot plot panels) or
CD4 against CD8.2 (bottom dot plot panels).
Percentages of CD4 SP, CD8 SP, CD4
CD8 DP, and CD4CD8 DN cell subsets
are indicated in the quadrants. FACS profiles
of thymocytes identified by plotting CD4
against CD8.1 were similar both for control
F1 mice and for CII/wt heterozygous mice.
In contrast, FACS profiles from CII/wt het-
erozygous mice obtained by plotting CD4
against CD8.2 were similar to those obtained
from CII homozygous mice shown in Figure
2. The result is representative of eight mice
analyzed.
the DN to DP stage (when the putative appropriate matu- Variegated Expression of CII-CD8 Allele on DP
Thymocytes of Heterozygous CII/wt Miceration signals would be available to activate the CII
allele), and the mutation phenotype would be repressed. CII-CD8.2/wt-CD8.1 heterozygous mice allowed us to
examine directly the activation of the CD8 locus in cellsAlternatively, if the effect of the deletion is dominant in
trans, then the wild-type allele might be affected, so that have accomplished the DN to DP transition. Thus,
thymocytes from such mice and (CBA/Ca x 129/Sv) F1that the thymus of this mouse would appear as in the
CII homozygote. Thymocytes isolated from CII/wt control mice were isolated and stained with antibodies
against CD8.1, CD8.2, and CD4. The different thymocyteheterozygous mice were isolated, stained with antibod-
ies against CD8.1, CD8.2, and CD4, and analyzed for subpopulations, as defined by wild-type allele (8.1) and
CD4 antibodies, were gated (Figure 5A, top panels), andexpression of the two CD8 alleles within the major
thymocyte subpopulations. Analysis of thymocytes by the pattern of expression of the mutated (8.2) allele was
determined. The results are shown as histograms inflow cytometry showed that subset distribution as iden-
tified by plotting CD8.1 (wt) against CD4 (top dot plot, Figure 5A, lower panels. In wild-type mice (CBA/Ca x
129/Sv) almost all of the DP and the majority of theFigure 4) was similar for both control (CBA/Ca x 129/
Sv) F1 wild-type mice and (CBA/Ca xCII) heterozygous CD8SP cells, as defined by CD8.1 and CD4 antibodies,
are also positive for CD8.2 expression. In contrast, inmice. This indicates that in the thymuses of CII/wt
mice, the deletion in one of the alleles does not affect (CBA/Ca x CII) heterozygous mice only 44.1% of the
DP and 39.2% of the CD8 SP thymocytes, as definedthe developmental progression to the DP stage. On the
other hand, analyses from CII/wt mice obtained by by CD8.1 and CD4 expression, carry the product from
the mutant allele (CD8.2) on their surface. This is consis-plotting CD4 against CD8.2 (bottom panel, right hand
side, Figure 4) were similar to those obtained from CII tent with a hypothesis that deletion of the CII regulatory
region causes variegation of expression of the CD8 lo-homozygous mutant mice, as described in previous sec-
tions. Thus, a reduction in cells falling in the (CD48.2) cus in the thymus particularly among the DP population.
When peripheral lymphocytes were analyzed in a similarDP gate and an increase of cells found in the CD48.2
SP gate are seen. This experiment indicates that the manner, it was found that variegation of the mutant allele
was reduced, with the majority 78.8% of the CD8.1 posi-two alleles are independently regulated in these mice
and that, even in the presence of an intact CD8 locus tive cells now also expressing the mutant allele. This
can be possible if cells that express both alleles havethat allows normal maturation of thymocytes, the ex-
pression of the mutated (CD8.2) allele is still perturbed. an advantage in maturation, migration, survival, and
maintenance processes. Alternatively, some of the cellsWe conclude that the phenotype observed inCII homo-
zygous mice is due to a direct cis effect on the activation that were positively selected while expressing only the
wild-type allele in the thymus gradually manage to acti-of expression of the CD8 locus caused by the deletion
of the CII regulatory sequences. vate the CD8 gene on the mutated locus with time.
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Figure 5. Variegated Expression of CII-CD8 Allele on DP Thymocytes of Heterozygous CII/wt Mice
(A) Analysis of thymocytes isolated from (129/Sv x CBA/Ca) F1 wild-type and CII/wt heterozygous mutant mice. The wild-type mice express
a wt-CD8.1 allele and a wt-CD8.2 allele, whereas the mutant mice express a CII-CD8.2 and a wt-CD8.1 allele. Thymocytes were isolated
and stained with anti-CD8.1, anti-CD4, and anti-CD8.2. Cell populations were identified by plotting CD4 against CD8.1. Percentages of CD4
SP, CD8 SP, CD4CD8 DP, and CD4CD8 DN cell subsets are indicated in the quadrants. Different cell populations (DN, double negative;
DP, double positive; CD4; CD8) were gated and analyzed for CD8.2 expression in the histograms shown underneath the corresponding dot
plot. The percentages of cells positive for CD8.2 are shown in the histograms. Eight heterozygous mice were analyzed with very similar results.
(B) Analysis of lymph node cells isolated from (129/Sv x CBA/Ca) F1 wild-type and CII/wt heterozygous mutant mice. Lymphocytes were
isolated and stained with anti-CD8.1, anti-CD4, and anti-CD8.2 and analyzed as described above.
(C) Possible mechanisms for the generation of the different immature subpopulations in CII mutant mice. Diagram of three probable ways
of thymocyte maturation in CII mutant mice. Circles indicate cell populations, and arrows show transition of cells from one population to
the other during maturation. (a) Cells can activate the CD8 locus but gradually lose CD8 gene expression, (b) they can aquire CD8 expression
slowly, or (c) there is variegation of CD8 expression with all cells arising from the DN population, but some cells activate the CD8 locus and
some cells remain negative.
Kinetics of CD8 Locus Activation during Thymocyte these mice contain a large number of immature appar-
ently DP cells that do not express the CD8 gene. How-Maturation in CII Mutant Mice
As documented above, deletion of Cluster II regulatory ever, it is not clear whether (1) these cells differentiate
from cells that had activated the CD8 locus and gradu-sequences from the CD8 locus results in a cis effect
that leads to its impaired activation. Thymocytes from ally lost expression of the CD8 gene, (2) they represent
Immunity
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Figure 6. Generation of Different Thymocyte Subpopulations during Ontogeny in CII Mutant Mice
Day E15 fetal lobes from CII/wt heterozygous mice and (129/Sv x CBA/Ca) F1 wild-type control mice were placed in culture and allowed to
develop for further 1 or 3 days. The mutant mice express a CII-CD8.2 and a wt-CD8.1 allele. Thymocytes were isolated from the fetal lobes
and stained with anti-CD8.1, anti-CD4, and anti-CD8.2.
(A) Analysis of thymocytes isolated from fetal lobes of CII/wt heterozygous mice at day E15 (top panels) or after 1 day in culture (bottom
panels). Cells were analyzed by plotting CD4 against CD8.1 or CD8.2. Percentages of CD4 SP, CD8 SP, and CD4CD8 DP cell subsets
are indicated in the quadrants.
(B) Thymocytes isolated from fetal lobes of CII/wt heterozygous mice were analyzed by plotting CD4 against CD8.1. DP thymocytes were
gated as indicated in the dot plot (gate A) and analyzed for CD8.2 expression in the histogram shown next to the dot plot. Cells negative
(gate B) or positive (gate C) for CD8.2 were gated.
(C) Percentages of cells within the CD4CD8.1CD8.2 (gate C) or the CD4CD8.1CD8.2 (gate B) population in days 1 and 3 of culture are
shown. The number of fetal lobes analyzed each day is shown (n  7 for day 1 and n  3 for day 3) The standard deviation of the samples
for each population and each day is also shown.
cells that are slow in activating the CD8 locus, or, finally, of CD4 or DP cells. The table presents the percentages
of such cells within the genuine DP population (as de-(3) whether these cells arise simultaneously and directly
from the DN population bearing a CD8 locus which is fined by the wild-type allele) in days 1 and 3 of E15 fetal
thymic lobe cultures. The ratio between DP and CD4 SPeither activated or silenced (Figure 5C).
Initial experiments trying to delineate the precursor/ appears to be the same between these two time points,
further supporting the idea that these two populationsproduct relationship between the DP and CD4SP thymo-
cytes in the CII mice using BrdU labeling suggested do not have a precursor/product relationship but that
they simultaneously arise directly from the DN popula-that the two populations incorporate BrdU at the same
rate indicating simultaneous generation of these popula- tion and independently from each other. It is possible
that this reflects a form of variegation of expression (ortions from the DN precursors. However, the presence
of cycling cells within these populations, as indicated initial activation) of the CII CD8 mutant locus, resulting
from the removal of HSS1 and 2 of Cluster II of DNaseIby the 7AAD staining shown in Figure 3B, made the
interpretation of this experiment difficult. hypersensitive sites.
In order to delineate the kinetics of generation of the
different immature subpopulations in the CII mutant Stability of the Phenotype of the Variegating
Thymocytesmice, their appearance during ontogeny was examined.
Precursor T cells derived from hematopoietic stem cells In order to analyze whether the two populations (DP and
CD4 SP) in the mutant mice can convert to each other,in fetal liver migrate to populate the thymus during em-
bryonic development. Until day E15, all thymocytes are their ability to reexpress the CD8 molecule on their sur-
face following pronase treatment was examined. Fordouble negative, and it is at day E16 that DP thymocytes
first appear. Thus, day E15 fetal lobes from (CBA/Ca x this purpose, thymocytes from normal or heterozygous
CII/wt mice were stained with antibodies against theCII) F1 heterozygous mice were placed in culture and
allowed to develop for further 1 or 3 days. Thymocytes wild-type allele (8.1), the mutant allele (8.2), and CD4.
DP thymocytes as defined by the wild allele and CD4from these fetal lobe cultures were subsequently stained
with antibodies against CD8.1, CD8.2, and CD4. Staining were gated and sorted according to the levels of expres-
sion of the mutant (8.2) allele. The two sorted popula-with the antibody that recognizes the wild-type allele
(8.1) product shows that mostly DP thymocytes appear tions (CD48.2 and CD48.2) were treated with pro-
nase and placed in culture at 37
C O/N in order to followwithin 24 hr with a small proportion of cells falling within
the CD4 gate. In contrast, within that same period both the ability of these cells to (re)express the CD8.2 mutant
allele. As shown in Figure 7, the CD4 8.2 populationcells that have activated the CD8.2 deleted locus and
cells that have not are evident. upregulates the CD8.2 molecules efficiently within 24
hr, suggesting that these cells contain CD8.2 mRNA andAs seen in the summary in Figure 6C, further matura-
tion did not show evidence of differential accumulation presumably have an open and active CD8.2 gene locus.
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Figure 7. Analysis of CD8 Expression on CD4 CD8.1 CD8.2lo and CD4 CD8.1 CD8.2hi Thymocytes by the Coreceptor Reexpression Assay
(A) Expression of CD8.2 in CD4 CD8.1 thymocytes is shown from CD8.1wt/CD8.2wt (control) and CD8.1wt/CD8.2 CII1,2 mice. CD8.2hi and
CD8.1lo populations were separated by cell sorting.
(B) Postsort analysis of CD8.2 expression on sorted cell populations.
(C and D) Cell populations were treated with pronase, cultured overnight at 4
C, and reanalyzed for CD8.2 expression. The experiment was
repeated twice with similar results.
In contrast, cells which were CD4 8.2 remained nega- a result of chromatin remodeling in thymocyte-specific
gene loci. Toward this goal, we present in this papertive for the mutant allele while retaining the ability to
reexpress the product from wild-type allele (8.1) (data the phenotype of mutant mice in which a regulatory
region upstream of the CD8 gene has been deletednot shown). This indicates that the deleted CD8.2 locus
is closed and inactive within these cells. Similar results by homologous recombination. This regulatory region
comprises two (HSS1 and 2) of the DNaseI hypersensi-were obtained when the sorted populations of cells were
transferred to FTOC for 3 days and were subsequently tive sites found in the Cluster II of hypersensitive sites
of the CD8 gene locus—the third hypersensitive sitereanalyzed, further supporting the hypothesis that the
activation (or not) of the CD8 locus in the mutated allele (HSS3) being the promoter of the CD8 gene (Hostert
et al., 1997a). In the past, this region has been shownis a stable state, at least within the time frame of these
experiments. to play a role in the regulation of the CD8 gene expres-
sion in transgenic animal studies and has been impli-
cated in the activation of a transgenic construct in theDiscussion
immature DP thymocyte stage of development (Hostert
et al., 1998).T cell differentiation depends on the coordinate activa-
tion of genetic loci that are specific for this cell lineage. Results presented in this paper indicate that these
regulatory sequences are important for the activationHow the different decisions during this maturation pro-
cess are taken is largely unclear. One way of addressing of the CD8 gene locus in cells that undergo the DN to
DP transition and further expansion. In mice lacking thethe problem is to follow changes in gene expression
that occur during the different developmental stages as CII region, only a proportion of thymocytes manage to
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activate the CD8 locus, whereas a large number of the its immediate flanking sequences but leaves the chro-
matin structure in the rest of the locus intact. Thus, itcells fail to do so. One explanation for this phenomenon
is that there are two distinct populations amongst the is possible that by removing the Cluster II hypersensitive
sites the topography of elements that can interact withDP cells, one which is dependent on the presence of
CII in order to activate the locus and one which is able the CD8 promoter are disturbed in such a way that
impairs its proper activation in all of the cells.to open the locus by using some other regulatory region
(e.g., hypersensitive Cluster IV) in the locus that has Whatever the mechanism, the phenotype described
here bears remarkable similarities to position-effect var-also been implicated in the early activation of the locus
(Ellmeier et al., 1998; Hostert et al., 1998). This would iegation: cells within the same lineage (as far as we can
tell) and having identical genetic makeup either decidehave repercussions on how we consider thymocyte de-
velopment, since until now it has been generally believed to open up the CD8 locus and become double-positive
CD48 thymocytes or decide to close down the locusthat the double-positive population is a homogeneous
population undecided about its lineage commitment and give rise to “DP wannabes,” which appear as single-
positive CD48 thymocytes in the analysis. To ourand whose fate is largely determined by the specificity
of the T cell receptor that it expresses. A heterogeneous knowledge, only one other occasion of such type of
disturbance in expression due to in situ deletion of regu-DP population hypothesis is not completely outlandish
considering that deletion of Cluster IV and Cluster III latory elements has been described. In that report, it
was shown that deletion of the Ig enhancer results inhypersensitive sites leads to a remarkably similar pheno-
type to the one described in this paper (Ellmeier et al., variegating expression of the immunoglobulin locus (Ro-
nai et al., 1999).2002). Therefore, it is conceivable that two distinct popu-
lations, one dependent on Cluster II regulatory regions In addition to the effects on the ability to open the
CD8 gene locus, deletion of Cluster II HSS1 and 2 hadand one dependent on Cluster IV, exist but cannot be
distinguished by flow cytometry in normal mice because an effect on the absolute levels of expression of CD8
on the surface of developing and mature T cells. Thus,both manage to activate the CD8 locus.
Alternatively, DP thymocytes are indeed a homoge- it is possible that this regulatory region, in addition to
determining chromatin structure, also contains ele-neous population, as far as the regulatory regions neces-
sary for the activation of the CD8 locus are concerned, ments (such as traditional enhancers) that contribute to
the full transcriptional capability of the locus.but the regulation of chromatin structure of the locus in
the mutant mice is perturbed. The ability to express or A chromatin structure hypothesis would entail the fol-
lowing: during the transition from DN to DP a processnot the genes within a locus depends on the state of
chromatin. Cooperation of all the regulatory elements is initiated which results in the activation of the CD8
locus in all developing thymocytes. Such initiationthat have been accumulated during evolution within this
locus ensures the timely and tissue-specific expression events are usually associated with extensive remodeling
of the chromatin, resulting in the establishment of anof the genes within this chromosomal site. Removal of
a gene from its usual chromosomal location such as in active/open chromatin domain (Paro, 1995; Pirrotta,
1997). It is possible that this process in the CD8 locustranslocations, deletions, or transgenesis can result in
aberrant patterns of expression, a phenomenon known relies on certain regulatory elements such as those pres-
ent in CII. However, maintenance of an active chromatinas position-effect variegation (PEV) (Festenstein and Ki-
oussis, 2000; Festenstein et al., 1996). In such cases, domain might be the responsibility of other regulatory
regions within the locus. The results in this paper arewithin a population of cells belonging to the same lin-
eage and containing identical genetic information, some consistent with a hypothesis that CII is mainly important
in ensuring the initiation events and that deletion ofcells open the locus and express the genes within it
whereas some cells silence them. The silencing is usu- these sequences leads to randomness in activation of
the locus manifesting itself as variegation in expression.ally concomitant with heterochromatinization of the lo-
cus, a process that has been attributed to the variable In those cells in which activation of the locus is randomly
achieved, other regions may take over the maintenance.extent to which heterochromatin can spread along the
chromosome from a nucleation point within different This is in agreement with the fact that another region in
the locus (namely, Cluster III), taken out of the CD8 locuscells (Karpen, 1994). Such heterochromatinization of a
locus is usually associated with loss of DNase I hyper- context and used in transgenic studies, is able to direct
expression of reporter genes only in the mature, posi-sensitivity (Festenstein et al., 1996). It is not clear
whether this mechanism underlies the phenomenon de- tively selected CD8 SP population. Such a specialized
role in initiation of a chromatin state has been recentlyscribed in this paper, where the locus has not been
removed from its natural location, but a crucial element attributed to the CD4 silencer (Zou et al., 2001).
A plausible hypothesis in how chromatin is involved infor its function has been deleted. In addition, DNaseI
hypersensitivity analysis showed that Cluster III (CIII) the phenomenon described in this paper is the following:
normally, the assembly of the multimolecular complexesremains hypersensitive (data not shown) in the cells that
have silenced the CD8 gene. This is not surprising in the CD8 locus, dictated by the primary sequences
of the DNA and their ability to bind specific factors,since it is known that hypersensitivity can be maintained,
while transcription is reduced (Bender et al., 2000). How- in collaboration with epigenetic mechanisms such as
phosphorylation and acetylation of histones, guaranteesever, the finding that the upstream Cluster III (CIII) re-
mains DNaseI hypersensitive (data not shown) in the that the locus will open and express in all the developing
thymocytes. By removing the DNaseI hypersensitivecells that have silenced the CD8 gene points more
toward a novel mechanism of inactivation as a result of Cluster II regulatory region, the locus becomes vulnera-
ble to suppressive effects that stochastically silence thea localized effect that involves only the CD8 gene and
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resistance gene flanked with loxP sites was ligated between up-locus in some cells but not in others. According to this
stream and downstream homology to give the targeting construct,hypothesis, in the absence of CII sequences the chroma-
1,2CII. This construct was linearized with NotI and used for ES celltin around the CD8 gene fails to remodel in all of the
transfection.
cells, giving rise to a large population of immature CD4
SP cells. These cells are destined to die unless they Transfection and Selection of ES Cells
express a TCR that can be selected with the available PC3 embryonic stem cells (O’Gorman et al., 1997) of 129/Sv origin
were maintained in the undifferentiated state by growth on a feederlevels of coreceptors. As a consequence there is a di-
layer of -irradiated primary embryonic fibroblasts using cultureminished pool of immature CD48 DP cells which in
medium supplemented with leukemia inhibitory factor (LIF) (Man-turn results in a decreased number of cells that can be
sour et al., 1988). Electroporation of 0.8  107 ES cells with 50 g/
positively selected as class I-restricted CD8 SP mature ml of linearized 1,2CII and selection of homologous recombined
T cells. positive clones with G418 (300 g/ml) and Gancyclovir (2 M) were
It is unclear at the moment how Cluster II participates carried out as described (Tybulewicz et al., 1991).
in chromosomal events that ensure the complete activa-
Generation of Mutant Micetion of the locus in all developing thymocytes. The possi-
Chimeric mice were generated by injection of selected euploid ESbility that the deletion has removed a functional element,
clones (chromosome number of 40) into 3.5 day blastocysts derivedsuch as a silencer or an insulator, cannot be excluded.
from C57Bl/10 females and transferring them into the uteri of foster
However, there has been no indication so far of the mothers. Chimeric males were bred to C57Bl/10 females, and germ-
presence of a silencer element in the CD8 locus. Another line transmission was determined by agouti coat color. In male chi-
aspect that may be relevant is the presence within this meric mice, expression of the CRE recombinase in the germline
resulted in the deletion of the loxP-flanked neomycin resistanceregion of sequences with matrix attachment site charac-
gene from the genome of the majority of the offspring. Heterozygousteristics described by Gottlieb and colleagues a few
mice were identified by Southern blot analysis (Southern, 1975) andyears ago (Banan et al., 1997; Lee et al., 1994). Removal
were bred to generate the homozygous mutant mice. The homozy-
of sequences that might anchor the locus in specific gous targeted mice that have deleted the neomycin resistance gene,
and required sites within the nucleus of the developing CII1,2/1,2neo, are designated as CII in this report. Homozygous
thymocyte may result in inaccessibility to specific chro- CII mice were crossed to CBA/Ca wild-type mice. The F1 progeny
is called CII/wt in this paper.matin factors necessary for its activation. An additional
characteristic of the CD8 locus is the presence of a large
Flow Cytometric Analysisnumber of Ikaros family binding sites, suggesting that
For sample analysis by flow cytometry, 106 thymocytes or T cellsthe members of this family may play an important role
were stained with the following antibodies in appropriate combina-
in the regulation of this locus. Ikaros members have tions: fluoresceine isocyanate (FITC)-conjugated anti-CD8/Lyt-2.1
been implicated in recruiting gene loci in the appropriate (49-11.1), FITC-conjugated anti-CD8 (YTS169), phycoerythrin (PE)-
conjugated anti-CD4 (H129.19, Pharmingen), tricolor (TC)-conju-compartments within a cell nucleus, as shown by Fisher
gated anti-CD8 (CT-CD8, Caltag), biotin-conjugated anti-TCRet al. (Brown et al., 1999). Results from our laboratory
(H57.597, Pharmingen), biotin-conjugated anti-CD5 (53-7.3, Phar-(our unpublished data) suggest that ability to bind Ikaros
mingen), biotin-conjugated anti-CD69 (H1.2F3, Pharmingen), biotin-family members is important for the activation of the
conjugated anti-HSA (YBM5.10), and biotin-conjugated anti-CD8/
CD8 locus. Therefore, by removing such sites one might Lyt-2.2 (2.43). Cells stained with biotin-conjugated antibodies were
decrease the probability of appropriate recruitment of stained subsequently with a second layer of streptavidin (SA)-red
670 (GIBCO-BRL). The CD8, CD8/Lyt-2.1, and CD8/Lyt-2.2 al-the locus in the proper nuclear compartments, thus im-
leles are called CD8, CD8.1, and CD8.2, respectively, in this paper.pairing the establishment of an active CD8 locus chro-
Three-color analysis by flow cytometry was carried out on a Bectonmatin domain and leading to a variegating pattern of
Dickinson FACSCalibur laser instrument and analyzed using CellCD8 expression. Experiments are on the way to define
Quest software.
further the state of the chromatin in the CD8 locus both
in normal and in CII mutant mice, as well as to define 7AAD Staining
particular factors associated with this region which For 7AAD staining, 106 cells were stained with PE-conjugated anti-
CD4 and FITC-conjugated anti-CD8 diluted in staining buffer (SB)might be important for the proper activation and mainte-
(PBS, 2% FCS, and 0.1% NaAzide). The cells were washed withnance of expression of the locus.
PBS-Azide, resuspended in 100 l SB/0.3% Saponin/7AAD (1 mg/
ml in 50% DMSO), and incubated in the dark at 37
C for 30 min.Experimental Procedures
Subsequently, the cells were left at 4
C for at least 30 min, and they
were acquired as they were in a Becton Dickinson FACScan laserGeneration of the 1,2CII Targeting Construct
instrument.For the generation of the targeting construct, the following steps
were taken. An 8.5 kb BamHI genomic fragment containing the CD8
Fetal Thymic Organ Culture (FTOC)gene and 6.9 kb upstream sequences was isolated from a 129/Sv
Fetal thymic lobes were isolated from day 15 embryos obtained phage genomic library ( FIX, Stratagene) and subcloned into
from timed matings of homozygous CII males with CBA/Ca femalepBluescript. A 2.2 kb BamHI-XbaI genomic fragment (upstream ho-
mice. The lobes were placed in culture and allowed to develop formology) was excised from this plasmid and was ligated into the
further 1 or 3 days. Thymocytes from these fetal lobe cultures wereXbaI site of pBluescript that had its BamHI site mutated and then
subsequently stained with anti-CD8/Lyt-2.1, anti-CD4, and anti-cut out as BamHI-XhoI fragment. This fragment was ligated into the
CD8/Lyt-2.2, and three-color analysis by flow cytometry was car-5.4 kb fragment, lacking the original neo gene, of the pPNT vector
ried out.(Tybulewicz et al., 1991). A further 2.5 kb EcoRI-BamHI fragment
with additional upstream homology was ligated into the targeting
construct in the 5	 end of the 2.2 kb BamHI-XbaI fragment, thus Pronase Treatment of Thymocytes
Isolation and analysis of CD4 CD8 T cells in CII1,2/wt mice byincreasing the overall homology to 4.7 kb. For downstream homol-
ogy, a 3.2 kb HindIII-BamHI genomic fragment was used, which was pronase treatment; pronase treatment of sorted cell populations
was performed as previously described (Suzuki et al., 1995). In brief,subcloned from the 8.5 kb BamHI fragment isolated from the 
phage library. Finally, a 1.4 kb fragment containing the neomycin CD4CD8.1CD8.2hi and CD4CD8.1CD8.2lo cells were separated
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by cell sorting on a MoFlo sorter (Cytomation) utilizing anti-CD4, Kioussis, D. (1997b). A region in the CD8 gene locus that directs
expression to the mature CD8 T cell subset in transgenic mice.anti-CD8.1, and anti-CD8.2 antibodies. The sorted cell populations
were either treated with 0.01% pronase (Sigma) for 2  10 min or Immunity 7, 525–536.
kept as controls. The cells were then cultured overnight at either Hostert, A., Garefalaki, A., Mavria, G., Tolaini, M., Roderick, K., Nor-
37
C to analyze CD8 reexpression or at 4
C as controls. Analysis of ton, T., Mee, P.J., Tybulewicz, V.L., Coles, M., and Kioussis, D.
CD8 expression on the populations of cells was performed on a (1998). Hierarchical interactions of control elements determine CD8
FACSCalibur (Becton Dickson) and reanalyzed using WinMDI re- gene expression in subsets of thymocytes and peripheral T cells.
analysis program (Scripps). Immunity 9, 497–508.
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